Integer Holdings Corporation (ITGR)
USD 110.46
(-2.85%)
USD 110.46
(-2.85%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 959.92 Million USD | -1.96% |
| 2022 | 979.12 Million USD | 12.2% |
| 2021 | 872.64 Million USD | 19.28% |
| 2020 | 731.61 Million USD | -10.16% |
| 2019 | 814.38 Million USD | -8.29% |
| 2018 | 888 Million USD | -43.75% |
| 2017 | 1.57 Billion USD | -7.07% |
| 2016 | 1.69 Billion USD | 0.82% |
| 2015 | 1.68 Billion USD | 856.06% |
| 2014 | 176.25 Million USD | -10.76% |
| 2013 | 197.5 Million USD | -12.38% |
| 2012 | 225.41 Million USD | -4.47% |
| 2011 | 235.95 Million USD | 6.94% |
| 2010 | 220.62 Million USD | -14.81% |
| 2009 | 258.97 Million USD | -26.62% |
| 2008 | 352.92 Million USD | 46.32% |
| 2007 | 241.19 Million USD | 41.88% |
| 2006 | 170 Million USD | 0.0% |
| 2005 | 170 Million USD | -0.38% |
| 2004 | 170.65 Million USD | -0.16% |
| 2003 | 170.92 Million USD | 124.17% |
| 2002 | 76.25 Million USD | 24.19% |
| 2001 | 61.39 Million USD | 98.37% |
| 2000 | 30.95 Million USD | -75.63% |
| 1999 | 126.98 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.11 Billion USD | -1.95% |
| 2024 Q1 | 1.14 Billion USD | 18.83% |
| 2024 Q3 | 1.07 Billion USD | -3.95% |
| 2023 Q3 | 1 Billion USD | -3.99% |
| 2023 Q1 | 1.06 Billion USD | 8.49% |
| 2023 FY | 959.92 Million USD | -1.96% |
| 2023 Q2 | 1.04 Billion USD | -1.34% |
| 2023 Q4 | 959.92 Million USD | -4.6% |
| 2022 Q4 | 979.12 Million USD | -0.64% |
| 2022 Q1 | 878.64 Million USD | 0.69% |
| 2022 Q2 | 996.32 Million USD | 13.39% |
| 2022 Q3 | 985.41 Million USD | -1.1% |
| 2022 FY | 979.12 Million USD | 12.2% |
| 2021 Q3 | 651.78 Million USD | -3.34% |
| 2021 Q2 | 674.32 Million USD | -2.94% |
| 2021 FY | 872.64 Million USD | 19.28% |
| 2021 Q1 | 694.78 Million USD | -5.04% |
| 2021 Q4 | 872.64 Million USD | 33.88% |
| 2020 Q4 | 731.61 Million USD | -12.97% |
| 2020 Q1 | 836.31 Million USD | 2.69% |
| 2020 Q2 | 970.93 Million USD | 16.1% |
| 2020 Q3 | 840.63 Million USD | -13.42% |
| 2020 FY | 731.61 Million USD | -10.16% |
| 2019 FY | 814.38 Million USD | -8.29% |
| 2019 Q4 | 814.38 Million USD | -1.78% |
| 2019 Q1 | 907.91 Million USD | 2.24% |
| 2019 Q3 | 829.14 Million USD | -4.17% |
| 2019 Q2 | 865.22 Million USD | -4.7% |
| 2018 Q3 | 916.69 Million USD | -39.03% |
| 2018 FY | 888 Million USD | -43.75% |
| 2018 Q4 | 888 Million USD | -3.13% |
| 2018 Q2 | 1.5 Billion USD | -1.66% |
| 2018 Q1 | 1.52 Billion USD | -3.15% |
| 2017 Q4 | 1.57 Billion USD | -1.44% |
| 2017 Q3 | 1.6 Billion USD | -2.3% |
| 2017 Q2 | 1.63 Billion USD | -1.72% |
| 2017 FY | 1.57 Billion USD | -7.07% |
| 2017 Q1 | 1.66 Billion USD | -1.8% |
| 2016 FY | 1.69 Billion USD | 0.82% |
| 2016 Q2 | 1.72 Billion USD | -0.33% |
| 2016 Q1 | 1.73 Billion USD | 2.88% |
| 2016 Q4 | 1.69 Billion USD | -1.07% |
| 2016 Q3 | 1.71 Billion USD | -0.62% |
| 2015 Q1 | 172.5 Million USD | -2.13% |
| 2015 Q2 | 168.75 Million USD | -2.17% |
| 2015 FY | 1.68 Billion USD | 856.06% |
| 2015 Q3 | 165 Million USD | -2.22% |
| 2015 Q4 | 1.68 Billion USD | 921.24% |
| 2014 FY | 176.25 Million USD | -10.76% |
| 2014 Q3 | 190 Million USD | -1.3% |
| 2014 Q4 | 176.25 Million USD | -7.24% |
| 2014 Q1 | 195 Million USD | -1.27% |
| 2014 Q2 | 192.5 Million USD | -1.28% |
| 2013 Q2 | 237 Million USD | 1.72% |
| 2013 Q1 | 233 Million USD | 3.37% |
| 2013 Q3 | 210 Million USD | -11.39% |
| 2013 Q4 | 197.5 Million USD | -5.95% |
| 2013 FY | 197.5 Million USD | -12.38% |
| 2012 Q3 | 230.15 Million USD | -1.38% |
| 2012 Q1 | 238.63 Million USD | 1.14% |
| 2012 FY | 225.41 Million USD | -4.47% |
| 2012 Q4 | 225.41 Million USD | -2.06% |
| 2012 Q2 | 233.37 Million USD | -2.21% |
| 2011 FY | 235.95 Million USD | 6.94% |
| 2011 Q4 | 235.95 Million USD | 18.98% |
| 2011 Q3 | 198.3 Million USD | -3.6% |
| 2011 Q2 | 205.7 Million USD | -7.82% |
| 2011 Q1 | 223.14 Million USD | 1.14% |
| 2010 FY | 220.62 Million USD | -14.81% |
| 2010 Q1 | 261.32 Million USD | 0.91% |
| 2010 Q4 | 220.62 Million USD | -7.75% |
| 2010 Q3 | 239.15 Million USD | -9.32% |
| 2010 Q2 | 263.72 Million USD | 0.92% |
| 2009 FY | 258.97 Million USD | -26.62% |
| 2009 Q2 | 277.37 Million USD | -12.11% |
| 2009 Q3 | 265.65 Million USD | -4.23% |
| 2009 Q4 | 258.97 Million USD | -2.52% |
| 2009 Q1 | 315.58 Million USD | -10.58% |
| 2008 Q2 | 355.94 Million USD | -0.73% |
| 2008 Q1 | 358.57 Million USD | 48.66% |
| 2008 FY | 352.92 Million USD | 46.32% |
| 2008 Q4 | 352.92 Million USD | 0.17% |
| 2008 Q3 | 352.31 Million USD | -1.02% |
| 2007 Q1 | 240.11 Million USD | 41.24% |
| 2007 FY | 241.19 Million USD | 41.88% |
| 2007 Q4 | 241.19 Million USD | 0.12% |
| 2007 Q3 | 240.9 Million USD | 0.16% |
| 2007 Q2 | 240.5 Million USD | 0.16% |
| 2006 Q1 | 170 Million USD | 0.0% |
| 2006 FY | 170 Million USD | 0.0% |
| 2006 Q3 | 170 Million USD | 0.0% |
| 2006 Q4 | 170 Million USD | 0.0% |
| 2006 Q2 | 170 Million USD | 0.0% |
| 2005 FY | 170 Million USD | -0.38% |
| 2005 Q1 | 170.4 Million USD | -0.14% |
| 2005 Q2 | 170.05 Million USD | -0.21% |
| 2005 Q3 | 170 Million USD | -0.03% |
| 2005 Q4 | 170 Million USD | 0.0% |
| 2004 FY | 170.65 Million USD | -0.16% |
| 2004 Q4 | 170.65 Million USD | -0.28% |
| 2004 Q3 | 171.13 Million USD | 0.12% |
| 2004 Q2 | 170.93 Million USD | 0.04% |
| 2004 Q1 | 170.87 Million USD | -0.03% |
| 2003 Q1 | 76.25 Million USD | 0.0% |
| 2003 Q3 | 170.9 Million USD | -0.04% |
| 2003 Q2 | 170.97 Million USD | 124.22% |
| 2003 Q4 | 170.92 Million USD | 0.01% |
| 2003 FY | 170.92 Million USD | 124.17% |
| 2002 FY | 76.25 Million USD | 24.19% |
| 2002 Q3 | 81.5 Million USD | 40.77% |
| 2002 Q1 | 57.89 Million USD | -5.7% |
| 2002 Q2 | 57.89 Million USD | 0.0% |
| 2002 Q4 | 76.25 Million USD | -6.44% |
| 2001 FY | 61.39 Million USD | 98.37% |
| 2001 Q1 | 35.91 Million USD | 16.04% |
| 2001 Q2 | 71.41 Million USD | 98.84% |
| 2001 Q3 | 68.41 Million USD | -4.2% |
| 2001 Q4 | 61.39 Million USD | -10.26% |
| 2000 FY | 30.95 Million USD | -75.63% |
| 2000 Q4 | 30.95 Million USD | -74.61% |
| 2000 Q3 | 121.89 Million USD | 0.0% |
| 1999 FY | 126.98 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott Laboratories | 13.59 Billion USD | 92.941% |
| Allurion Technologies Inc. | 2.3 Million USD | -41527.277% |
| Artivion, Inc. | 305.53 Million USD | -214.183% |
| Avanos Medical, Inc. | 159.4 Million USD | -502.211% |
| Butterfly Network, Inc. | 22.83 Million USD | -4103.744% |
| Butterfly Network, Inc. | 22.83 Million USD | -4103.744% |
| Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 19.297% |
| Boston Scientific Corporation | 8.96 Billion USD | 89.288% |
| CONMED Corporation | 971.48 Million USD | 1.19% |
| Edwards Lifesciences Corporation | 670 Million USD | -43.272% |
| Paragon 28, Inc. | 109.79 Million USD | -774.257% |
| Glaukos Corporation | 383.73 Million USD | -150.151% |
| Globus Medical, Inc. | 417.4 Million USD | -129.977% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -3763.499% |
| Medtronic plc | 23.87 Billion USD | 95.98% |
| Myomo, Inc. | 115.16 Thousand USD | -833457.659% |
| Nevro Corp. | 211.47 Million USD | -353.927% |
| Owlet, Inc. | 22 Thousand USD | -4363195.455% |
| Penumbra, Inc. | 220.9 Million USD | -334.534% |
| Vicarious Surgical Inc. | 13.78 Million USD | -6863.547% |
| Smith & Nephew plc | 2.17 Billion USD | 55.866% |
| Sonendo, Inc. | 14.03 Million USD | -6739.508% |
| STERIS plc | 3.12 Billion USD | 69.235% |
| Stryker Corporation | 10.9 Billion USD | 91.194% |
| Vapotherm, Inc. | 109.97 Million USD | -772.834% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 80.281% |